Vendor, New York, NY
The Global Alliance for TB Drug Development Inc.
UEI CA1RNRESAZU6, CAGE 52VM4
1 award and $0 obligated between August 20, 2025 and August 26, 2026, 100% under full and open competition, against 18.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93024C00008Definitive Contract, August 20, 2025, Full and Open Competition, 18 offers | National Institutes of Health NiaidNational Institutes of Health | To Develop a Novel Modulator Targeting Proteostasis for the Treatment of M. Tuberculosis.NAICS 541715, PSC AN12 | $0 |
- Places of performance
- New York
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 4 across 1 awards